Genetic screening in 2,710 infertile candidate couples for assisted reproductive techniques: results of application of Italian guidelines for the appropriate use of genetic tests

Fertility and Sterility

Volumn 89, Issue 4, 2008, Pages 800-808

  Riccaboni, Alessandra ^a   Lalatta, Faustina ^a   Caliari, Ilaria ^a   Bonetti, Silvia ^a   Somigliana, Edgardo ^a   Ragni, Guido ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

ART; chromosome aberrations; cystic fibrosis; genetic screening

Indexed keywords

TRANSMEMBRANE CONDUCTANCE REGULATOR;

ARTICLE; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC SCREENING; HUMAN; INFERTILITY; INFERTILITY THERAPY; ITALY; KARYOTYPING; MAJOR CLINICAL STUDY; MALE; PREGNANCY; PRIORITY JOURNAL; SPERMATOZOON;

ADULT; CHROMOSOME ABERRATIONS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; FERTILIZATION IN VITRO; GENE FREQUENCY; GENETIC SCREENING; GUIDELINE ADHERENCE; HUMANS; INFANT, NEWBORN; INFERTILITY; INSEMINATION, ARTIFICIAL; ITALY; KARYOTYPING; MALE; MUTATION; PATIENT SELECTION; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PROGRAM EVALUATION; REPRODUCTIVE TECHNIQUES, ASSISTED; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 41949086042     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2007.04.032     Document Type: Article

References (40)

1. Silber S.J., Nagy Z., Liu J., Tournaye H., Lissens W., Ferec C., et al. The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility. Hum Reprod 10 (1995) 2031-2043
2. Scholtes M.C., Behrend C., Dietzel-Dahmen J., van Hoogstraten D.G., Marx K., Wohlers S., et al. Chromosomal aberrations in couples undergoing intracytoplasmic sperm injection: influence on implantation and ongoing pregnancy rates. Fertil Steril 70 (1998) 933-937
3. Bor P., Hindkjær J., Kølvraa S., and Ingerslev J. Y-chromosome microdeletions and cytogenetic findings in unselected ICSI candidates at a Danish fertility clinic. J Assist Reprod Genet 19 (2002) 224-231
4. Male Infertility Best Practice Policy Committee of the American Urological Association and Practice Committee of the American Society for Reproductive Medicine. Report on optimal evaluation of the infertile male. Fertil Steril 82 Suppl 1 (2004) S123-S130
5. Schreurs A., Legius E., Meuleman C., Fryns J.P., and D'Hooghe T.M. Increased frequency of chromosomal abnormalities in female partners of couples undergoing in vitro fertilization or intracytoplasmic sperm injection. Fertil Steril 74 (2000) 94-96
6. Van der Ven K., Peschka B., Montag M., Lange R., Schwanitz G., and van der Ven H.H. Increased frequency of congenital chromosomal aberrations in female partners of couples undergoing intracytoplasmic sperm injection. Hum Reprod 13 (1998) 48-54
7. Peschka B., Leygraaf J., Van der Ven K., Montag M., Schartmann B., Schubert R., et al. Type and frequency of chromosome aberrations in 781 couples undergoing intracytoplasmic sperm injection. Hum Reprod 14 (1999) 2257-2263
8. Gekas J., Thepot F., Turleau C., Siffroi J.P., Dadoune J.P., Briault S., et al. Chromosomal factors of infertility in candidate couples for ICSI: an equal risk of constitutional aberrations in women and men. Hum Reprod 16 (2001) 82-90
9. Meschede D., Lemcke B., Exeler J.R., De Geyter C., Behre H.M., Nieschlag E., and Horst J. Chromosome abnormalities in 447 couples undergoing intracytoplasmic sperm injection-prevalence, types, sex distribution and reproductive relevance. Hum Reprod 13 (1998) 576-582
10. Foresta C., Ferlin A., Gianaroli L., and Dallapiccola B. Guidelines for the appropriate use of genetic tests in infertile couples. Eur J Hum Genet 10 (2002) 303-312
11. Mitelman F. ISCN 1995. An international system for human cytogenetic nomenclature (1995), Karger, Basel, Switzerland
12. Chillon M., Casals T., Mercier B., Bassas L., Lissens W., Silber S., et al. Mutations in the cystic fibrosis gene in patients with congenital absence of the vas deferens. N Engl J Med 332 (1995) 1475-1480
13. Hook E.B., and Hamerton J.L. The frequency of chromosome abnormalities detected in consecutive new-born studies. Differences between studies. Results by sex and severity of phenotypic involvement. In: Hook E.B., and Porter I.H. (Eds). Population cytogenetics. New York State Department of Health, Birth Defects Institute, symposium, Albany, New York, October 1975 (1975), Academic Press, New York 63-79
14. Jacobs P.A., Browne C., Gregson N., Joyce C., and White H. Estimates of the frequency of chromosome abnormalities detectable in unselected newborns using moderate levels of banding. J Med Genet 29 (1992) 103-108
15. Nielsen J., and Wohlert M. Chromosome abnormalities among 34910 newborn children: results from 13-year incidence study in Arhus, Denmark. Hum Genet 87 (1991) 81-83
16. Clementini E., Palka C., Iezzi I., Stuppia L., Guanciali-Franchi P., and Tiboni G.M. Prevalence of chromosomal abnormalities in 2,078 infertile couples referred for assisted reproductive techniques. Hum Reprod 20 (2005) 437-442
17. Foresta C., Garolla A., Bartoloni L., Bettella A., and Ferlin A. Genetic abnormalities among severely oligospermic men who are candidates for intracytoplasmic sperm injection. J Clin Endocrinol Metab 90 (2005) 152-156
18. Papanikolaou E.G., Vernaeve V., Kolibianakis E., Assche E.V., Bonduelle M., Liebaers I., et al. Is chromosome analysis mandatory in the initial investigation of normovulatory women seeking infertility treatment?. Hum Reprod 20 (2005) 2899-2903
19. Sonntag B., Meschede D., Ullmann V., Gassner P., Horst J., Nieschlag E., and Behre H.M. Low-level sex chromosome mosaicism in female partners of couples undergoing ICSI therapy does not significantly affect treatment outcome. Hum Reprod 16 (2001) 1648-1652
20. Simpson J.L. Disorders of sex chromosomes and sexual differentiation. In: Simpson J.L., and Golbus M.S. (Eds). Genetics in obstetrics and gynaecology (1992), WB Saunders, Philadelphia, PA 133-164
21. Gardner R.J.M., and Sutherland G.R. Chromosome abnormalities and genetic counselling. 3rd edition (2004), Oxford University Press, New York
22. Silverstein S., Lerer I., Sagi M., Frumkin A., Ben-Neriah Z., and Abeliovich D. Uniparental disomy in fetuses diagnosed with balanced Robertsonian translocations: risk estimate. Prenat Diagn 22 (2002) 649-651
23. Hamosh A., FitzSimmons S.C., Macek Jr. M., Knowles M.R., Rosenstein B.J., and Cutting G.R. Comparison of the clinical manifestations of cystic fibrosis in black and white patients. J Pediatr 132 (1998) 255-259
24. Casals T., Bassas L., Ruiz-Romero J., Chillon M., Gimenez J., Ramos M.D., et al. Extensive analysis of 40 infertile patients with congenital absence of the vas deferens: in 50% of cases only one CFTR allele could be detected. Hum Genet 95 (1995) 205-211
25. Dork T., Dworniczak B., Aulehla-Scholz C., Wieczorek D., Bohm I., Mayerova A., et al. Distinct spectrum of CFTR gene mutations in congenital absence of vas deferens. Hum Genet 100 (1997) 365-377
26. Mak V., Zielenski J., Tsui L.C., Durie P., Zini A., Martin S., et al. Proportion of cystic fibrosis gene mutations not detected by routine testing in men with obstructive azoospermia. JAMA 281 (1999) 2217-2224
27. Mickle J., Milunsky A., Amos J.A., and Oates R.D. Congenital unilateral absence of the vas deferens: a heterogeneous disorder with two distinct subpopulations based upon aetiology and mutational status of the cystic fibrosis gene. Hum Reprod 10 (1995) 1728-1735
28. Stuppia L., Antonucci I., Binni F., Brandi A., Grifone N., Colosimo A., et al. Screening of mutations in the CFTR gene in 1,195 couples entering assisted reproduction technique programs. Eur J Hum Genet 13 (2005) 959-964
29. Doherty R.A. National Institutes of Health consensus development conference statement on genetic testing for cystic fibrosis. J Med Screen 4 (1997) 179-180
30. American College of Obstetricians and Gynecologists [ACOG]. Preconception and prenatal carrier screening for cystic fibrosis: clinical laboratory guidelines (2001), ACOG, Washington, DC 1-31
31. Grody W.W., Cutting G.R., Klinger K.W., Richards C.S., Watson M.S., and Desnick R.J. Subcommittee on Cystic Fibrosis Screening, Accreditation of Genetic Services Committee, ACMG. American College of Medical Genetics. Laboratory standards and guidelines for population-based cystic fibrosis carrier screening. Genet Med 3 (2001) 149-154
32. Haddow J.E., Palomaki G.E., Bradley L.A., and Doherty R.A. Screening for cystic fibrosis. JAMA 279 (1998) 1068
33. Health Council of the Netherlands, and Committee of Genetic Screening. Genetic screening (No. 1994/22E) (1994), Health Council of the Netherlands, The Hague, the Netherlands
34. Haddow J.E., Bradley L.A., Palomaki G.E., Doherty R.A., Bernhardt B.A., Brock D.J., et al. Issues in implementing prenatal screening for cystic fibrosis: results of a working conference. Genet Med 1 (1999) 129-135
35. Wildhagen M.F., Ten Kate L.P., and Habbema J.D. Screening for cystic fibrosis and its evaluation. Br Med Bull 54 (1998) 857-875
36. Langfelder-Schwind E., Kloza E., Sugarman E., Pettersen B., Brown T., Jensen K., et al. National Society of Genetic Counselors Subcommittee on Cystic Fibrosis Carrier Testing. Cystic fibrosis prenatal screening in genetic counseling practice: recommendations of the National Society of Genetic Counselors. J Genet Couns 14 (2005) 1-15
37. Raeburn J.A. Screening for carriers of cystic fibrosis. Screening before pregnancy is needed. BMJ 309 (1994) 1428-1429
38. Henneman L., Bramsen I., van der Ploeg H.M., and ten Kate L.P. Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genet Test 6 (2002) 195-202
39. Poppelaars F.A., Henneman L., Ader H.J., Cornel M.C., Hermens R.P., van der Wal G., et al. Preconceptional cystic fibrosis carrier screening: attitudes and intentions of the target population. Genet Test 8 (2004) 80-89
40. Henneman L., Bramsen I., van Kempen L., van Acker M.B., Pals G., van der Horst H.E., et al. Offering preconceptional cystic fibrosis carrier couple screening in the absence of established preconceptional care services. Community Genet 6 (2003) 5-13